Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2975 of 5804
-
Blood pressure drug may help kids with rare genetic condition
Disease control CompletedThe Williams-Beuren syndrome (WBS) is a sporadic congenital disorder characterized by a multisystem developmental impairment. This syndrome is caused by a microdeletion in chromosome 7q11.23 that encompasses loss of the elastin locus. Elastin, which is part of the extracellular …
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New stroke drug shows promise in early safety trial
Disease control CompletedThe objectives of this study are to assess the safety, tolerability and local tolerance, and to investigate the plasma levels and terminal elimination half life of MCI-186, and to review the routine clinical and neurological assessments data of MCI-186 in subjects with acute isch…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Glowing dye could help surgeons spot hidden lung cancer spread
Knowledge-focused OngoingThe primary purpose of this study is to determine if we can identify the first lymph node that drains from the tumor, and thus would be the most likely site for metastatic disease, and remove it for analysis to improve the ability to detect tumor in this node and to remove this a…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Old drugs, new hope: imatinib combo tested for rare tumors
Disease control CompletedThe purpose of this study is to determine the maximum tolerated dose of imatinib mesylate, given in association with a fixed dose of cyclophosphamide (50 mg bid).
Phase: PHASE1 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Gum treatment may help diabetes patients manage blood sugar
Disease control CompletedThis study will assess the efficacy of periodontal treatment in diabetic patient. Patients will be randomized in the periodontal group or in the control group. The control group will received a periodontal treatment after the study.
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Rabies shot under the skin: could it work?
Prevention CompletedThe purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.
Phase: NA • Sponsor: Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New bone graft shows promise in neck fusion surgery
Disease control CompletedThis is a prospective, non-randomized multi-center study to compare the use of Osteocel Plus in subjects who receive ACDF surgery at one or two levels. These subjects will present with degenerative conditions in the cervical spine that are amenable to surgical treatment and will …
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a measles shot soothe eczema? small trial investigates
Symptom relief CompletedAtopic dermatitis (AD) is a chronic inflammatory disease of the skin. AD is very frequent, and involves T lymphocytes cells. Measles vaccination, as well as measles vaccine, induces a temporary immunosuppression; furthermore, an improvement of AD has been observed during measles …
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Gene test may predict chemo side effects in breast cancer patients
Knowledge-focused CompletedRATIONALE: Identifying genes that increase a person's susceptibility to side effects caused by capecitabine may help doctors plan better treatment. PURPOSE: This clinical trial is studying blood samples in predicting response to capecitabine in women with metastatic breast cance…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can garlic and enzymes make menopause hormones safer?
Disease control CompletedThe purpose of this study is to determine whether Hormone Replacement Therapy (HRT), safety studies are combined with herbal (garlic oil, rutin, and nattokinase) to reduce estrogen side effects. Making it safer when an endocrine supplement is needed for estrogen deficiency sympto…
Phase: PHASE4 • Sponsor: Trieu, Nguyen Thi, M.D. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
1,000 lupus patients join hunt for skin disease genes
Knowledge-focused Recruiting nowApproximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their disease. Cutaneous lupus erythematosus represents the skin manifestations of systemic lupus erythematosus, …
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Drug combo shows promise in Hard-to-Treat cancers
Disease control CompletedBackground: * Bevacizumab inhibits blood vessel growth in cancer cells by blocking a growth factor called VEGF. Dasatinib inhibits the action of proteins called tyrosine kinases, which promote and stimulate blood vessel formation and cancer growth and spread. * Using the two dru…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug MCI-196 tested for safety in dialysis patients with high phosphorus
Disease control CompletedThe primary objective of this study is to demonstrate the long-term safety and tolerability of MCI-196 in the subjects with stage V chronic kidney disease on dialysis with hyperphosphatemia. The secondary objective of this study is to assess the long-term efficacy of flexible do…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New device could protect tiny babies from dangerous low blood sugar
Disease control CompletedHypoglycemia is frequent in very low birth weight (VLBW) neonates and compromises their neurological outcome. The aim of this study was to compare real-time continuous glucose monitoring system (RT-CGMS) to standard method by intermittent capillary blood glucose testing in detect…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Silver patch may shield fragile newborns from deadly infections
Prevention CompletedThe purpose of this study is to determine whether silver alginate (Algidex) patch is effective in the prevention of central line infections in very low birth weight infants.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Scientists dig into the mystery of unexplained allergic shock
Knowledge-focused OngoingThis study will explore the possible cause of unexplained, or idiopathic, anaphylaxis. Anaphylaxis is a rapid, life-threatening, severe reaction that occurs suddenly after contact with an allergy-causing substance, usually a particular food, drug or stinging insect. The allergen …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Could a dialysis filter help heart attack survivors?
Disease control CompletedRationale: Despite spontaneous cardiac activity recovery, a shock occurs in more than half of patients after resuscitation for cardiac arrest. This acute circulatory insufficiency presents similar characteristics with septic shock and is responsible of most early deaths. Most fre…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Scientists probe blood vessel role in skin disorders
Knowledge-focused Recruiting nowThe researchers believe that pro-angiogenic factors are upregulated in a wide range of dermatologic diseases, including port wine stains, hemangiomas, angiofibromas, Kaposi's sarcoma, angiosarcoma, scars, rosacea, and psoriasis. Select specimens may undergo genetic analysis to in…
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Back pain breakthrough? simple program may keep healthcare workers on their feet
Prevention CompletedAt Lyon University Medical Center, back problems are the leading cause of sick leave. The course of lower back pain is usually relatively short (recovery occurs within 4 to 6 weeks in 90% of cases). However, about 5-10% develop chronic lower back pain. Although this is a relative…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
New MRI could spot hidden heart disease in women without invasive scans
Knowledge-focused OngoingThis research study is designed to investigate the approaches to noninvasive detection and assessment of coronary vascular dysfunction in women by comparing the testing results from the invasive standard care diagnostic procedure Angiogram and from the additional noninvasive diag…
Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:09 UTC